Results 351 to 360 of about 216,147 (379)
Some of the next articles are maybe not open access.
Arthritis & Rheumatology, 2020
To describe the levels and trends of point prevalence, annual incidence, and years lived with disability (YLD) for gout and its attributable risk factors in 195 countries and territories from 1990 to 2017 according to age, sex, and Sociodemographic Index
S. Safiri +14 more
semanticscholar +1 more source
To describe the levels and trends of point prevalence, annual incidence, and years lived with disability (YLD) for gout and its attributable risk factors in 195 countries and territories from 1990 to 2017 according to age, sex, and Sociodemographic Index
S. Safiri +14 more
semanticscholar +1 more source
Mechanisms and rationale for uricase use in patients with gout
Nature Reviews Rheumatology, 2023Naomi Schlesinger +2 more
semanticscholar +1 more source
Clinical evidence, 2005
Gout affects about 5% of men and 1% of women, with up to 80% of people experiencing a recurrent attack within 3 years.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for acute gout? What are the effects of treatments to prevent gout in people with prior acute episodes?
openaire +6 more sources
Gout affects about 5% of men and 1% of women, with up to 80% of people experiencing a recurrent attack within 3 years.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for acute gout? What are the effects of treatments to prevent gout in people with prior acute episodes?
openaire +6 more sources
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Drugs, 2023R. Terkeltaub
semanticscholar +1 more source
Current Opinion in Rheumatology, 2002
Gout continues to be a health problem around the world despite the availability of effective therapies. Although the prevalence is influenced by genetic factors, the associations of alcohol consumption, obesity, and hypertension appear to be partially responsible for the increased prevalence of gout and hyperuricemia in African and Oriental countries ...
openaire +2 more sources
Gout continues to be a health problem around the world despite the availability of effective therapies. Although the prevalence is influenced by genetic factors, the associations of alcohol consumption, obesity, and hypertension appear to be partially responsible for the increased prevalence of gout and hyperuricemia in African and Oriental countries ...
openaire +2 more sources
Annals of Internal Medicine
Gout is characterized by deposition of monosodium urate (MSU) crystals in or around joints, tendons, bursae, and other tissues, resulting in painful recurrent flares and tissue damage. Gout is the most common form of inflammatory arthritis, with a prevalence of 5.1% in the United States, affecting 12.1 million adults. When urate levels exceed the limit
openaire +2 more sources
Gout is characterized by deposition of monosodium urate (MSU) crystals in or around joints, tendons, bursae, and other tissues, resulting in painful recurrent flares and tissue damage. Gout is the most common form of inflammatory arthritis, with a prevalence of 5.1% in the United States, affecting 12.1 million adults. When urate levels exceed the limit
openaire +2 more sources